Clin2
NCT04812431Possibly a fitRecruiting

Tested stem cell transplant therapy for severe spinal cord injury

Spinal Cord Injury, AcuteSpinal Cord Injury at C4 Level With Complete LesionSpinal Cord Injury at C5-C7 Level With Complete Lesion

Part of Brain & nervous system, Injuries & trauma clinical trials.

This trial tests a cell transplant approach for people with a very severe spinal cord injury. It focuses first on safety and also looks for early signs the therapy may improve function.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
5 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You (or your legal representative) must give written consent to join
  • You must be between 18 and 65 years old
  • Your injury must be a spinal cord injury that happened within 7 to 60 days before the treatment day
  • Your spinal cord injury must be classified as AIS-A (complete injury) confirmed by specialist tests
  • Your MRI must show no more than 2 cm of lesion length, and you must not have multiple lesions
  • You must be able to receive the study treatment safely, including physical therapy and general anesthesia when needed

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06841770Recruiting· Phase 1
Testing a delivery device for spinal cord injury treatment

This trial tests a device that delivers a special cell therapy (LCTOPC1) into the spinal cord. It is for people with a recent or chronic spinal cord injury that is severe (no feeling or movement below the injury) or leaves some sensation but no movement.

Downey, California
NCT06922890Recruiting· Phase 1/Phase 2
Gene therapy for chronic spinal cord injury (AIS-A/B)

This trial tests a new gene therapy called STUP-001 that aims to repair spinal cord damage directly. It is for people who have had a traumatic spinal cord injury with complete or near-complete paralysis (AIS-A or B) for at least 6 months.

Seoul
NCT06976229Recruiting· Phase 1
Stem cell therapy for recent spinal cord injury

This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.

Guangzhou, Guangdong
NCT06974968Not yet recruiting· Phase 2
Cell therapy for recent spinal cord injury

This trial tests whether a new cell therapy (XS228) can help people with recent spinal cord injuries recover function. The cells are given through a spinal tap and are designed to replace damaged nerve cells.

Guangzhou, Guangdong
NCT07739043Not yet recruiting· Early Phase 1
Spinal cord injury treatment with injected cells

This study tests a new treatment for spinal cord injury that is given through a spinal tap. It is for people with a recent or past spinal cord injury who are at least 18 years old. The treatment may help improve recovery.

Chicago, Illinois
NCT07596563Not yet recruiting· Phase 1
Cell transplant and rehab for chronic spinal cord injury

This trial tests whether transplanting cells from your nose, combined with intensive exercise therapy, can help repair long-term spinal cord injuries. You'll receive a surgical procedure and then participate in structured rehabilitation five days a week for several months.

Hear when a new Spinal Cord Injury, Acute trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.